INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
MiNK Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$9.56+0.15 (+1.59%)
Close on Oct 19, 2026
- Market cap
- $48.02M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
4.0%
0M of 5M shares
Institutional holders
27
7 new, 3 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 8 sales
Net sold $46.62K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Gkcc, LLC | 4,640,000 | 11.79% | 13G (passive) | May 14, 2024 |
| Garo H. Armen | 3,514,320 | 9.68% | 13D (active) | Jan 16, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of INKT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 68,660 | 1.35% | $802.64K | +9,296 | 0.00% |
| DnB Asset Management AS | 55,142 | 1.08% | $644.61K | New | 0.00% |
| Longbow Finance SA | 16,667 | 0.33% | $194.84K | – | 0.02% |
| Geode Capital Management, LLC | 15,573 | 0.31% | $182.08K | −1,772 | 0.00% |
| Citadel Advisors LLC | 15,440 | 0.30% | $180.49K | New | 0.00% |
| BlackRock, Inc. | 13,382 | 0.26% | $156.44K | +7,179 | 0.00% |
| Vanguard Fiduciary Trust Co | 8,287 | 0.16% | $96.88K | – | 0.00% |
| UBS Group AG | 4,885 | 0.10% | $57.11K | −10,317 | 0.00% |
| Steward Partners Investment Advisory, LLC | 2,000 | 0.04% | $23.38K | – | 0.00% |
| US Bancorp \de\ | 1,995 | 0.04% | $23.32K | New | 0.00% |
| Paladin Partners, LLC | 1,000 | 0.02% | $11.69K | – | 0.01% |
| Federation des caisses Desjardins du Quebec | 500 | 0.01% | $5.85K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 422 | 0.01% | $4.93K | +266 | 0.00% |
| Covestor Ltd | 119 | 0.00% | $1 | – | 0.00% |
| Osaic Holdings, Inc. | 117 | 0.00% | $1.37K | +116 | 0.00% |
| Morgan Stanley | 113 | 0.00% | $1.32K | +9 | 0.00% |
| Barclays PLC | 24 | 0.00% | $281 | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 18 | 0.00% | $210 | +8 | 0.00% |
| Northwestern Mutual Wealth Management Co | 18 | 0.00% | $210 | – | 0.00% |
| Game Plan Financial Advisors, LLC | 16 | 0.00% | $187 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 27 | 0M | 4.0% | 7 / 6 | 3 / 3 | 0M | 0M |
| Q1 2026 | 23 | 0M | 2.5% | 5 / 2 | 4 / 5 | 0M | 0M |
| Q4 2025 | 24 | 0M | 3.0% | 6 / 3 | 7 / 0 | 0M | 0M |
| Q3 2025 | 18 | 0M | 1.8% | 2 / 6 | 2 / 3 | 0M | 0M |
| Q2 2025 | 19 | 0M | 1.2% | 4 / 5 | 5 / 1 | 0M | 0M |
| Q1 2025 | 16 | 0M | 0.9% | 16 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of INKT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 53,070 | 1.04% | $620.39K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 15,382 | 0.30% | $179.82K | 0.00% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 6,734 | 0.13% | $78.72K | 0.01% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 6,599 | 0.13% | $80.51K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 1,902 | 0.04% | $23.20K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 1,883 | 0.04% | $22.97K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 1,389 | 0.03% | $16.95K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 445 | 0.01% | $5.20K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 208 | 0.00% | $2.43K | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -200 | -0.00% | -$2.34K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Melissa Orilall | Principal Financial Officer | 222 | 0.00% | Apr 9, 2026 |
| Austin Charette | Principal Accounting Officer | 40 | 0.00% | Mar 23, 2026 |
| Jennifer Buell | Chief Executive Officer | 57,942 | 1.14% | Jan 14, 2026 |
| Brian Corvese | Director | 54,770 | 1.07% | Sep 2, 2026 |
| John Bradley Holcomb | Director | 4,691 | 0.09% | Sep 2, 2026 |
| Ulf Wiinberg | Director | 51,759 | 1.01% | Sep 2, 2026 |
| Barbara Ryan | Director | 23,591 | 0.46% | Sep 2, 2026 |
| Peter Behner | Director | 24,404 | 0.48% | Sep 2, 2026 |
| Robert Peter Kadlec | Director | 19,126 | 0.37% | Dec 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John Bradley Holcomb Director | Sep 1, 2026 | Award | +1,233 | $10.95 | $13.50K | 4,691 |
| Ulf Wiinberg Director | Sep 1, 2026 | Award | +1,279 | $10.95 | $14.01K | 23,929 |
| Brian Corvese Director | Sep 1, 2026 | Award | +1,633 | $10.95 | $17.88K | 54,770 |
| Peter Behner Director | Sep 1, 2026 | Award | +1,485 | $10.95 | $16.26K | 24,404 |
| Barbara Ryan Director | Sep 1, 2026 | Award | +1,622 | $10.95 | $17.76K | 23,591 |
| Barbara Ryan Director | Jun 4, 2026 | Sale | −500 | $12.68 | $6.34K | 22,969 |
| Barbara Ryan Director | Jun 4, 2026 | Sale | −1,000 | $12.80 | $12.80K | 21,969 |
| Ulf Wiinberg Director | Jun 1, 2026 | Award | +1,131 | $12.38 | $14.00K | 22,650 |
| John Bradley Holcomb Director | Jun 1, 2026 | Award | +1,091 | $12.38 | $13.51K | 3,458 |
| Barbara Ryan Director | Jun 1, 2026 | Award | +1,434 | $12.38 | $17.75K | 23,469 |
| Brian Corvese Director | Jun 1, 2026 | Award | +1,444 | $12.38 | $17.88K | 53,137 |
| Peter Behner Director | Jun 1, 2026 | Award | +1,313 | $12.38 | $16.25K | 22,919 |
| Barbara Ryan Director | Mar 10, 2026 | Sale | −300 | $15.28 | $4.58K | 21,406 |
| Barbara Ryan Director | Mar 10, 2026 | Sale | −500 | $15.57 | $7.79K | 20,906 |
| Barbara Ryan Director | Mar 10, 2026 | Sale | −500 | $15.30 | $7.65K | 20,406 |
| Barbara Ryan Director | Mar 9, 2026 | Sale | −200 | $10.17 | $2.03K | 21,706 |
| Ulf Wiinberg Director | Mar 2, 2026 | Award | +1,285 | $10.90 | $14.01K | 21,519 |
| John Bradley Holcomb Director | Mar 2, 2026 | Award | +1,239 | $10.90 | $13.51K | 2,367 |
| Barbara Ryan Director | Mar 2, 2026 | Award | +1,629 | $10.90 | $17.76K | 22,035 |
| Brian Corvese Director | Mar 2, 2026 | Award | +1,640 | $10.90 | $17.88K | 51,693 |
| Peter Behner Director | Mar 2, 2026 | Award | +1,491 | $10.90 | $16.25K | 21,606 |
| Barbara Ryan Director | Mar 2, 2026 | Sale | −100 | $10.83 | $1.08K | 21,906 |
| Barbara Ryan Director | Feb 27, 2026 | Sale | −400 | $10.86 | $4.34K | 22,006 |
| Jennifer Buell Chief Executive Officer | Jan 2, 2026 | Tax withholding | −10,024 | $11.12 | $111.47K | 57,942 |
| Jennifer Buell Chief Executive Officer | Jan 2, 2026 | Award | +31,474 | $11.12 | $349.99K | 67,966 |
| John Bradley Holcomb Director | Dec 1, 2025 | Award | +1,128 | $11.09 | $12.51K | 1,128 |
| Peter Behner Director | Dec 1, 2025 | Award | +1,466 | $11.09 | $16.26K | 20,115 |
| Robert Peter Kadlec Director | Dec 1, 2025 | Award | +1,218 | $11.09 | $13.51K | 19,126 |
| Ulf Wiinberg Director | Dec 1, 2025 | Award | +1,263 | $11.09 | $14.01K | 20,234 |
| Barbara Ryan Director | Dec 1, 2025 | Award | +1,601 | $11.09 | $17.76K | 22,406 |
| Brian Corvese Director | Dec 1, 2025 | Award | +1,612 | $11.09 | $17.88K | 50,053 |
| Jennifer Buell Chief Executive Officer | Sep 9, 2025 | Tax withholding | −5,351 | $15.36 | $82.19K | 36,492 |
| Jennifer Buell Chief Executive Officer | Sep 9, 2025 | Award | +18,229 | $15.36 | $280.00K | 41,913 |
| Barbara Ryan Director | Sep 2, 2025 | Award | +1,281 | $13.86 | $17.75K | 20,805 |
| Robert Peter Kadlec Director | Sep 2, 2025 | Award | +975 | $13.86 | $13.51K | 17,908 |
| Ulf Wiinberg Director | Sep 2, 2025 | Award | +1,011 | $13.86 | $14.01K | 18,971 |
| Brian Corvese Director | Sep 2, 2025 | Award | +1,290 | $13.86 | $17.88K | 48,441 |
| Peter Behner Director | Sep 2, 2025 | Award | +1,173 | $13.86 | $16.26K | 18,649 |
| Brian Corvese Director | Jun 2, 2025 | Award | +2,494 | $7.17 | $17.88K | 47,151 |
| Ulf Wiinberg Director | Jun 2, 2025 | Award | +1,953 | $7.17 | $14.00K | 17,960 |
| Barbara Ryan Director | Jun 2, 2025 | Award | +2,476 | $7.17 | $17.75K | 19,524 |
| Robert Peter Kadlec Director | Jun 2, 2025 | Award | +1,883 | $7.17 | $13.50K | 4,647 |
| Peter Behner Director | Jun 2, 2025 | Award | +2,267 | $7.17 | $16.25K | 17,476 |
| Brian Corvese Director | Mar 3, 2025 | Award | +2,033 | $8.79 | $17.87K | 44,657 |
| Robert Peter Kadlec Director | Mar 3, 2025 | Award | +1,536 | $8.79 | $13.50K | 2,764 |
| Barbara Ryan Director | Mar 3, 2025 | Award | +2,019 | $8.79 | $17.75K | 17,048 |
| Ulf Wiinberg Director | Mar 3, 2025 | Award | +1,593 | $8.79 | $14.00K | 16,007 |
| Peter Behner Director | Mar 3, 2025 | Award | +1,849 | $8.79 | $16.25K | 15,209 |
| Robert Peter Kadlec Director | Dec 1, 2024 | Award | +12,286 | $0.73 | $8.97K | 12,286 |
| Barbara Ryan Director | Dec 1, 2024 | Award | +24,229 | $0.73 | $17.69K | 150,336 |
| Peter Behner Director | Dec 1, 2024 | Award | +20,987 | $0.73 | $15.32K | 133,634 |
| Ulf Wiinberg Director | Dec 1, 2024 | Award | +20,476 | $0.73 | $14.95K | 144,181 |
| Brian Corvese Director | Dec 1, 2024 | Award | +24,400 | $0.73 | $17.81K | 426,283 |
| Ulf Wiinberg Director | Sep 3, 2024 | Award | +18,295 | $0.82 | $15.00K | 123,705 |
| Barbara Ryan Director | Sep 3, 2024 | Award | +21,649 | $0.82 | $17.75K | 126,107 |
| Peter Behner Director | Sep 3, 2024 | Award | +18,753 | $0.82 | $15.38K | 109,234 |
| Brian Corvese Director | Sep 3, 2024 | Award | +21,802 | $0.82 | $17.88K | 405,296 |
| Peter Behner Director | Jun 3, 2024 | Award | +15,454 | $0.99 | $15.30K | 90,481 |
| Brian Corvese Director | Jun 3, 2024 | Award | +17,967 | $0.99 | $17.79K | 383,494 |
| Ulf Wiinberg Director | Jun 3, 2024 | Award | +15,077 | $0.99 | $14.93K | 105,410 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Jennifer Buell Officer, PRESIDENT AND CHIEF EXECUTIVE OFFICER | Oct 13, 2026 | 6,938 | $73.27K | Oct 12, 2026 | RESTRICTED STOCK UNITS VESTING |
| Inc. Agenus Owner | Aug 29, 2025 | 786,750 | $12.57M | Aug 29, 2025 | These shares were acquired in an original issuance from the issuer, which was incorporated as a wholly owned subsidiary of Agenus Inc. |